GX1 GENXONE NewConnect · quarterly · publ. August 12, 2026

Q2 2026 report

Mała spółka biotechnologiczna z NewConnect (sekwencjonowanie NGS/nanoporowe, diagnostyka molekularna), wciąż przed progiem rentowności, ale z wyraźnie poprawiającym się trendem operacyjnym.

Sentiment

Neutral No guidance change

Website

GX1 Q2 2026 report

Revenue

566,922 PLN

— YoY

Net income

-328,637 PLN

— YoY

EBITDA

-181,017 PLN

— YoY

FCF

-219,688 PLN

— YoY

Summary

Investment thesis

Przychody rosną (+15,7% r/r w Q2 2026), a tempo strat wyraźnie maleje (strata netto -328,6 tys. PLN vs -571,6 tys. PLN rok wcześniej).
Bilans bez zadłużenia odsetkowego, ale gotówka topnieje (-34,1% r/r, do 2 857,9 tys. PLN) w tempie ok. -543,0 tys. PLN OCF za I półrocze 2026.
Dwa nowe kontrakty usługowe podpisane w trakcie/tuż po kwartale (łącznie >1,27 mln PLN: WUM 93 990,45 PLN i Human Biome 1 180 800,00 PLN) powinny wesprzeć przychody w III/IV kwartale 2026.
Kluczowe pytanie: czy tempo poprawy operacyjnej wystarczy, by osiągnąć dodatni OCF zanim wyczerpie się gotówka — przy obecnym tempie wypalania teoretyczny runway to ok. 2,5-3 lata.

Read the full analysis

Financial data is open to everyone. The full analysis — management verdict, commentary, risks, and the full narrative — is available after you sign up or log in.

Financials

BETA

Q2 2026

GX1 · Q2 2026

Metric	Q2 2026	Q2 2025	Δ YoY	YTD 2026	Δ YoY	Value type	Segment	Conf.

Revenue	566,922	—	—	1,057,855	—	reported	—	1.00
EBITDA	-181,017	—	—	-541,258	—	derived	—	0.90
EBIT	-349,362	—	—	-888,295	—	reported	—	1.00
Net income	-328,637	—	—	-845,616	—	reported	—	1.00
D&A	168,345	—	—	347,037	—	reported	—	1.00
Income tax	8,096	—	—	12,057	—	reported	—	1.00
Shares (basic) (units)	3,304,820	—	—	—	—	reported	—	1.00

EBITDA margin	-31.93%	—	—	-51.16%	—	derived	—	0.90
EBIT margin	-61.62%	—	—	-83.95%	—	derived	—	0.90
Net margin	-57.98%	—	—	-79.94%	—	derived	—	0.90

Cash	2,857,943	—	—	—	—	reported	—	1.00
Total debt	0	—	—	—	—	reported	—	1.00
Net debt	-2,857,943	—	—	—	—	derived	—	0.95
Equity	7,564,710	—	—	—	—	reported	—	1.00
Total assets	7,975,894	—	—	—	—	reported	—	1.00
Working capital	3,169,445	—	—	—	—	derived	—	0.95
Current assets	3,505,652	—	—	—	—	reported	—	1.00
Current liabilities	336,207	—	—	—	—	reported	—	1.00
Non-current liabilities	0	—	—	—	—	reported	—	1.00
Inventory	142,369	—	—	—	—	reported	—	1.00
Trade receivables	261,084	—	—	—	—	reported	—	1.00
Trade payables	58,592	—	—	—	—	reported	—	1.00
Goodwill	4,250,459	—	—	—	—	reported	—	1.00
Tangible equity	3,314,251	—	—	—	—	derived	—	0.90

CFO	-219,688	—	—	-543,011	—	reported	—	1.00
CapEx	0	—	—	0	—	reported	—	1.00
FCF	-219,688	—	—	-543,011	—	derived	—	0.95

Current ratio	10.43x	—	—	—	—	derived	—	0.95
Quick ratio	10x	—	—	—	—	derived	—	0.95
Cash ratio	8.5x	—	—	—	—	derived	—	0.95

Debt / equity	0x	—	—	—	—	derived	—	1.00
Debt / assets	0x	—	—	—	—	derived	—	1.00
Net debt / equity	-0.38x	—	—	—	—	derived	—	0.95

Revenue growth (YoY)	15.65%	—	—	15.33%	—	derived	—	0.95
EBITDA growth (YoY)	48.71%	—	—	36.4%	—	derived	—	0.85
EBIT growth (YoY)	43.63%	—	—	36.8%	—	derived	—	0.95
Net income growth (YoY)	42.51%	—	—	35.15%	—	derived	—	0.95

Q2 2026 · Δ YoY

Revenue

566,922 —

Q2 2025: —
YTD 2026: 1,057,855
Δ YoY: —

EBITDA

-181,017 —

Q2 2025: —
YTD 2026: -541,258
Δ YoY: —

EBIT

-349,362 —

Q2 2025: —
YTD 2026: -888,295
Δ YoY: —

Net income

-328,637 —

Q2 2025: —
YTD 2026: -845,616
Δ YoY: —

D&A

168,345 —

Q2 2025: —
YTD 2026: 347,037
Δ YoY: —

Income tax

8,096 —

Q2 2025: —
YTD 2026: 12,057
Δ YoY: —

Shares (basic) (units)

3,304,820 —

Q2 2025: —
YTD 2026: —
Δ YoY: —

EBITDA margin

-31.93% —

Q2 2025: —
YTD 2026: -51.16%
Δ YoY: —

EBIT margin

-61.62% —

Q2 2025: —
YTD 2026: -83.95%
Δ YoY: —

Net margin

-57.98% —

Q2 2025: —
YTD 2026: -79.94%
Δ YoY: —

Cash

2,857,943 —

Q2 2025: —
YTD 2026: —
Δ YoY: —

Total debt

0 —

Q2 2025: —
YTD 2026: —
Δ YoY: —

Net debt

-2,857,943 —

Q2 2025: —
YTD 2026: —
Δ YoY: —

Equity

7,564,710 —

Q2 2025: —
YTD 2026: —
Δ YoY: —

Total assets

7,975,894 —

Q2 2025: —
YTD 2026: —
Δ YoY: —

Working capital

3,169,445 —

Q2 2025: —
YTD 2026: —
Δ YoY: —

Current assets

3,505,652 —

Q2 2025: —
YTD 2026: —
Δ YoY: —

Current liabilities

336,207 —

Q2 2025: —
YTD 2026: —
Δ YoY: —

Non-current liabilities

0 —

Q2 2025: —
YTD 2026: —
Δ YoY: —

Inventory

142,369 —

Q2 2025: —
YTD 2026: —
Δ YoY: —

Trade receivables

261,084 —

Q2 2025: —
YTD 2026: —
Δ YoY: —

Trade payables

58,592 —

Q2 2025: —
YTD 2026: —
Δ YoY: —

Goodwill

4,250,459 —

Q2 2025: —
YTD 2026: —
Δ YoY: —

Tangible equity

3,314,251 —

Q2 2025: —
YTD 2026: —
Δ YoY: —

CFO

-219,688 —

Q2 2025: —
YTD 2026: -543,011
Δ YoY: —

CapEx

0 —

Q2 2025: —
YTD 2026: 0
Δ YoY: —

FCF

-219,688 —

Q2 2025: —
YTD 2026: -543,011
Δ YoY: —

Current ratio

10.43x —

Q2 2025: —
YTD 2026: —
Δ YoY: —

Quick ratio

10x —

Q2 2025: —
YTD 2026: —
Δ YoY: —

Cash ratio

8.5x —

Q2 2025: —
YTD 2026: —
Δ YoY: —

Debt / equity

0x —

Q2 2025: —
YTD 2026: —
Δ YoY: —

Debt / assets

0x —

Q2 2025: —
YTD 2026: —
Δ YoY: —

Net debt / equity

-0.38x —

Q2 2025: —
YTD 2026: —
Δ YoY: —

Revenue growth (YoY)

15.65% —

Q2 2025: —
YTD 2026: 15.33%
Δ YoY: —

EBITDA growth (YoY)

48.71% —

Q2 2025: —
YTD 2026: 36.4%
Δ YoY: —

EBIT growth (YoY)

43.63% —

Q2 2025: —
YTD 2026: 36.8%
Δ YoY: —

Net income growth (YoY)

42.51% —

Q2 2025: —
YTD 2026: 35.15%
Δ YoY: —